VT
MRNA icon

Vise Technologies’s Moderna MRNA Stock Holding History

Vise Technologies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Buy
+5,447
New +$282K ﹤0.01% 1315
2023
Q2 		– Sell
-1,486
Closed -$228K – 361
2023
Q1 		$228K Buy
+1,486
New +$245K 0.06% 298

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Vise Technologies's MRNA Position: Q2 2026 in Review

Vise Technologies opened a new position in Moderna (MRNA) in Q2 2026: 5,447 shares worth $381K. The stake represents ﹤0.01% of the portfolio and ranks #1315 among its holdings. This is a return to the name: Vise Technologies previously reported a position in MRNA as recently as Q1 2023.

Vise Technologies first reported a position in MRNA in Q1 2023 and has held it in 2 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vise Technologies held 5,447 shares of Moderna worth $381K as of Q2 2026.
  • Moderna was a new Vise Technologies position in Q2 2026.
  • Moderna made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1315 holding.
  • Vise Technologies first reported a position in Moderna in Q1 2023 and has held it in 2 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.